Nearly 600,000 bottles of blood pressure pills recalled over cancer risk

"Check your medicine cabinet: A major pharmaceutical company has just recalled nearly 600,000 bottles of a blood pressure medication due to the potential presence of a potentially cancer-causing chemical. According to three different recall notices shared by the FDA, the New Jersey-based drugmaker Teva Pharmaceuticals USA has voluntarily recalled several lots of the blood pressure medication prazosin hydrochloride. Here's what to know:"

"Essentially, that means drug testing found that the affected bottles contained a concentration of nitrosamine -a potential carcinogen-that was above the acceptable levels established by the FDA. The FDA has categorized this recall as a Class II, meaning, "a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.""

"The recall includes bottles of Prazosin Hydrochloride in 1 mg, 2 mg, and 5 mg concentrations. There are three different recall numbers for each of these doses, cinlduing: D-0104-2026; 181,659 bottles of a 1 mg dosage D-0105-2026; 291,512 bottles of a 2 mg dosage D-0106-2026; 107,673 of a 5 mg dosage"

Teva Pharmaceuticals USA voluntarily recalled about 590,000 bottles of prazosin hydrochloride after tests detected N-nitroso Prazosin impurity C above the FDA CPCA acceptable intake limit. Testing found a concentration of a nitrosamine, a potential carcinogen, that exceeded FDA acceptable levels. The FDA classified the recall as Class II, indicating exposure may cause temporary or medically reversible adverse health consequences or that serious adverse outcomes are unlikely. Affected strengths include 1 mg (181,659 bottles), 2 mg (291,512 bottles), and 5 mg (107,673 bottles). Patients with the medication should contact their pharmacy for return instructions; full lot numbers are available.

Read at Fast Company